Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
28
-
Total shares
-
9.05M
-
Shares change
-
+9.05M
-
Total reported value, excl. options
-
$108M
-
Value change
-
+$108M
-
Number of buys
-
28
-
Price
-
$11.89
Significant Holders of Adicet Bio, Inc. - COM (ACET) as of Q3 2020
28 filings reported holding ACET - Adicet Bio, Inc. - COM as of Q3 2020.
Adicet Bio, Inc. - COM (ACET) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.05M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.71M shares), Johnson & Johnson Innovation - JJDC, Inc. (663K shares), Nantahala Capital Management, LLC (415K shares), Ikarian Capital, LLC (274K shares), BAILLIE GIFFORD & CO (182K shares), BlackRock Inc. (134K shares), Artal Group S.A. (129K shares), ACADIAN ASSET MANAGEMENT LLC (107K shares), VANGUARD GROUP INC (93.8K shares), and DAFNA Capital Management LLC (67.6K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.